Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2018

Open Access 01-12-2018 | Research article

Antituberculosis activity, phytochemical identification of Costus speciosus (J. Koenig) Sm., Cymbopogon citratus (DC. Ex Nees) Stapf., and Tabernaemontana coronaria (L.) Willd. and their effects on the growth kinetics and cellular integrity of Mycobacterium tuberculosis H37Rv

Authors: Suriyati Mohamad, Nur Najihah Ismail, Thaigarajan Parumasivam, Pazilah Ibrahim, Hasnah Osman, Habibah A. Wahab

Published in: BMC Complementary Medicine and Therapies | Issue 1/2018

Login to get access

Abstract

Background

Costus speciosus, Cymbopogon citratus, and Tabernaemontana coronaria are herbal plants traditionally used as remedies for symptoms of tuberculosis (TB) including cough. The aims of the present study were to evaluate the in vitro anti-TB activity of different solvent partitions of these plants, to identify the phytochemical compounds, and to assess the effects of the most active partitions on the growth kinetics and cellular integrity of the tubercle organism.

Methods

The in vitro anti-TB activity of different solvent partitions of the plant materials was determined against M. tuberculosis H37Rv using a tetrazolium colorimetric microdilution assay. The phytochemical compounds in the most active partition of each plant were identified using gas chromatography-mass spectrometry (GC-MS) analysis. The effects of these partitions on the growth kinetics of the mycobacteria were evaluated over 7-day treatment period in a batch culture system. Their effects on the mycobacterial cellular integrity were observed under a scanning electron microscope (SEM).

Results

The respective n-hexane partition of C. speciosus, C. citratus, and T. coronaria exhibited the highest anti-TB activity with minimum inhibitory concentrations (MICs) of 100–200 μg/mL and minimum bactericidal concentration (MBC) of 200 μg/mL. GC-MS phytochemical analysis of these active partitions revealed that majority of the identified compounds belonged to lipophilic fatty acid groups. The active partitions of C. speciosus and T. coronaria exhibited high cidal activity in relation to time, killing more than 99% of the cell population. SEM observations showed that these active plant partitions caused multiple structural changes indicating massive cellular damages.

Conclusions

The n-hexane partition of the plant materials exhibited promising in vitro anti-TB activity against M. tuberculosis H37Rv. Their anti-TB activity was supported by their destructive effects on the integrity of the mycobacterial cellular structure.
Literature
1.
2.
3.
4.
Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–43.CrossRefPubMed
5.
O'Brien RJ, Nunn PP. The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps. Am J Respir Crit Care Med. 2001;163(5):1055–8.CrossRefPubMed
6.
Sacks LV, Behram RE. Challenges, successes, and hopes in the development of novel TB therapeutics. Future Med Chem. 2009;1(4):749–56.CrossRefPubMed
7.
Verpoorte R. Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discov Today. 1998;3:232–8.CrossRef
8.
Aiyegoro OA, Okoh AI. Use of bioactive plant products in combination with standard antibiotics: implications in antimicrobial chemotherapy. J Med Plants Res. 2009;3(13):1147–52.
9.
10.
Chin WY. A guide to medicinal plants. Singapore: Singapore Science Centre; 2002.
11.
Chooi OH. Tumbuhan liar, khasiat ubatan dan kegunaan lain. Kuala Lumpur: Utusan Publications and Distributors Sdn Bhd; 2004.
12.
13.
Saraf A. Phytochemical and antimicrobial studies of medicinal plant Costus speciosus (Koen.) E-J. Chem. 2010;7(S1):S405–13.
14.
Shah G, Shri R, Panchal V, Sharma N, Singh B, Mann AS. Scientific basis for the therapeutic use of Cymbopogon citratus, Stapf (lemon grass). J Adv Pharm Technol Res. 2011;2(1):3–8.CrossRefPubMedPubMedCentral
15.
Abubakar IB, Loh HSA. Review on ethnobotany, pharmacology and phytochemistry of Tabernaemontana corymbosa. J Pharm Pharmacol. 2016;68(4):423–32.CrossRefPubMed
16.
Mohamad S, Zin NM, Wahab HA, Ibrahim P, Sulaiman SF, Zahariluddin ASM, Noor SSMN. Antituberculosis potential of some ethnobotanically selected Malaysian plants. J Ethnopharmacol. 2011;133:1021–6.CrossRefPubMed
17.
Jones WP, Kinghorn AD. Extraction of plant secondary metabolites. Methods Mol Biol. 2012;864:341–66.CrossRefPubMed
18.
Caviedes L, Delgado J, Gilman RH. Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J Clin Microbiol. 2002;40(5):1873–4.CrossRefPubMedPubMedCentral
19.
Marshall NJ, Goodwin CJ, Holt SJ. A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regulat. 1995;5(2):69–84.
20.
Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev. 2005;11:127–52.CrossRefPubMed
21.
Clinical and Laboratory Standards Institute (CLSI). Methods for determining bactericidal activity of anti-microbial agents. In: Wayne, editor. Approved guideline, CLSI document M26-A. Pennsylvania: CLSI; 1998.
22.
23.
Mohamad S, Ibrahim P, Sadikun A. Susceptibility of Mycobacterium tuberculosis to isoniazid and its derivative, 1-isonicotinyl-2-nonanoyl hydrazine: investigation at cellular level. Tuberculosis. 2004;84:56–62.CrossRefPubMed
24.
Hoben HJ, Somasegaran P. Comparison of pour, spread and drop plate methods for enumeration of Rhizobium spp. in inoculants made from presterilised peat. Appl Environ Microbiol. 1982;44:1246–7.PubMedPubMedCentral
25.
Heifets L, Lindholm-Levy P. Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and Mycobacterium tuberculosis. Antimicrob Agents Ch. 1989;33(8):1298–301.CrossRef
26.
Bakker-Woudenberg IAJM, van Vianen W, van Soolingen D, Henri AV, van Agtmael MA. Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination. Antimicrob Agents Ch. 2005;49(6):2387–98.CrossRef
27.
de Steenwinkel JEM, De Knegt GJ, Ten Kate MT, Van Belkum A, Verbrugh HA, Kremer K, Van Soolingen D, Bakker-Woudenberg IAJM. Time-kill kinetics of antituberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis. J Antimicrob Chemoth. 2010;65(12):2582–9.CrossRef
28.
Yamori S, Ichiyama S, Shimokata K, Tsukamura M. Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases. Microbiol Immunol. 1992;36:361–8.CrossRefPubMed
29.
Takayama K, Wang L, Merkal RS. Scanning electron microscopy of the H37Ra strain of Mycobacterium tuberculosis exposed to isoniazid. Antimicrob Agents Ch. 1973;4:62–5.CrossRef
30.
van Boxtel RM, Lambrecht RS, Collins MT. Effects of polyoxyethylene sorbate compounds (tweens) on colonial morphology, growth, an ultrastructure of Mycobacterium paratuberculosis. Acta Pathol Microbiol Immunol Scand. 1990;98:901–18.CrossRef
31.
Verbelen C, Dupres V, Menozzi FD, Raze D, Baulard AR, Hols P, Dufrenel YF. Ethambutol-induced alterations in Mycobacterium bovis BCG imaged by atomic force microscopy. FEMS Microbiol Lett. 2006;264(2):192–7.CrossRefPubMed
32.
Newton SM, Lau C, Wright CWA. Review of antimycobacterial natural products. Phytother Res. 2000;14:303–22.CrossRefPubMed
33.
Okunade AL, Elvin-Lewis MP, Lewis WH. Natural antimycobacterial metabolites: current status. Phytochemistry. 2004;65(8):1017–32.CrossRefPubMed
34.
Mmushi TJ, Masoko P, Mdee LK, Mokgotho MP, Mampuru LJ, Howard RL. Antimycobacterial evaluation of fifteen medicinal plants in South Africa. Afr J Trad. 2010;7(1):34–9.
35.
Luo X, Pires D, Ainsa J, Gracia B, Mulhovo S, Duarte A, Anes E, Ferreira MJ. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique. J Ethnopharmacol. 2011;37:114–20.CrossRef
36.
Otsuka H. Purification by solvent extraction using partition coefficient. In: Sarker SD, Latif Z, Gray AI, editors. Methods in biotechnology: natural product isolation. 2nd edn. New Jersey: Humana Press; 2006. p. 269–74.CrossRef
37.
Brennan PJ. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis. 2003;83:91–7.CrossRefPubMed
38.
Alderwick LJ, Harrison J, Lloyd GS, Birch HL. The mycobacterial cell wall-peptidoglycan and arabinogalactan. Spring Harb Perspect Med. 2015;5:a021113.CrossRef
39.
Zhang Y, Young D. Molecular genetics of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemoth. 1994;34:313–39.CrossRef
40.
Smith T, Wolff KA, Nguyen L. Molecular biology of drug resistance in Mycobacterium tuberculosis. Curr Top Microbiol Immunol. 2013;374:53–80.PubMedPubMedCentral
41.
42.
Copp BR, Pearce AN. Natural product growth inhibitors of Mycobacterium tuberculosis. Nat Prod Rep. 2007;24(2):278–97.CrossRefPubMed
43.
Samarth RM, Samarth M, Matsumoto Y. Medicinally important aromatic plants with radioprotective activity. Future Science OA. 2017;3(4) doi:https://​doi.​org/​10.​4155/​fsoa-2017-0061.​
44.
National Committee for Clinical Laboratory Standards (NCCLS). In: Wayne, editor. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; tentative standard M24–T2. 2nd ed. Philadelphia: NCCLS; 2000.
45.
Andersen P, Askgaard D, Ljungqvist L, Bennedsen J, Heron I. Proteins released from Mycobacterium tuberculosis during growth. Infect Immun. 1991;59(6):1905–10.PubMedPubMedCentral
46.
Mohamad S, Ibrahim P, Wahab HA. Effects of isoniazid on viability, cell morphologies and acid fastness properties of Mycobacterium avium NCTC 8559 during the growth cycle. Chemotherapy. 2007;53:263–6.CrossRefPubMed
47.
Takayama K, Wang L, David HL. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Ch. 1972;2(1):29–35.CrossRef
48.
49.
50.
Buddelmeijer N, Beckwith J. Assembly of cell division proteins at the E. coli cell centre. Curr Opin Microbiol. 2002;5:553–7.CrossRefPubMed
51.
52.
Dahl JL. Electron microscopy analysis of Mycobacterium tuberculosis cell division. FEMS Microbiol Letters. 2004;240:15–20.CrossRef
53.
Farnia P, Masjedi MR, Farnia P, Merza MA, Tabarsi P, Zhavnerko GK, Ibrahim TA, Kuan HO, Ghanavei J, Farnia P, Ranjbar R, Poleschuyk NN, Titov LP, Owlia P, Kazampour M, Setare M, Sheikolslami M, Migliori GB, Velayati AA. Growth and cell division in extensive (XDR) and extremely drug resistant (XXDR) tuberculosis strains: transmission and atomic force observation. Int J Clin Exp Med. 2010;3:320–6.
54.
Malhotra S, Bhatia NK, Kaushal M, Kaur N, Chauhan A. Pleomorphic appearance in Mycobacterium tuberculosis. J Public Health Epidemiol. 2010;2:11–2.
55.
Chatterjee KR, Gupta NND, De ML. Electron microscopic observations on the morphology of Mycobacterium leprae. Exp Cell Res. 1959;18:521–7.CrossRefPubMed
56.
Winder FG, Rooney SA. The effects of isoniazid on the carbohydrates of Mycobacterium tuberculosis BCG. Biochem J. 1970;177:355–68.CrossRef
57.
Bardou F, Quemard A, Dupont M, Horn C, Marchal G, Daffe M. Effects of isoniazid on ultrastructure of Mycobacterium aurum and Mycobacterium tuberculosis and on production of secreted proteins. Antimicrob Agents Ch. 1996;40:2459–67.
58.
Velayati AA, Farnia P. Morphological characterisation of Mycobacterium tuberculosis. In: Cardona PJ, editor. Understanding tuberculosis - deciphering the secret life of the bacilli. Croatia: InTech Publisher; 2012. p. 149–66.
Metadata
Title
Antituberculosis activity, phytochemical identification of Costus speciosus (J. Koenig) Sm., Cymbopogon citratus (DC. Ex Nees) Stapf., and Tabernaemontana coronaria (L.) Willd. and their effects on the growth kinetics and cellular integrity of Mycobacterium tuberculosis H37Rv
Authors
Suriyati Mohamad
Nur Najihah Ismail
Thaigarajan Parumasivam
Pazilah Ibrahim
Hasnah Osman
Habibah A. Wahab
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2018
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-2077-5

Other articles of this Issue 1/2018

BMC Complementary Medicine and Therapies 1/2018 Go to the issue

Research article

Genotoxicity evaluation of So-ochim-tang-gamibang (SOCG), a herbal medicine

Research article

Phenolic profile and biological properties of the leaves of Ficus vasta Forssk. (Moraceae) growing in Egypt

Research article

Gancao (Glycyrrhizae Radix) provides the main contribution to Shaoyao-Gancao decoction on enhancements of CYP3A4 and MDR1 expression via pregnane X receptor pathway in vitro

Research article

Astragalus membranaceus (Fisch.) Bunge repairs intestinal mucosal injury induced by LPS in mice

Research article

Anti-aging potential of extracts from Sclerocarya birrea (A. Rich.) Hochst and its chemical profiling by UPLC-Q-TOF-MS

Research article

Induction of programmed cell death in Trypanosoma cruzi by Lippia alba essential oils and their major and synergistic terpenes (citral, limonene and caryophyllene oxide)